However, patients with negative PD-L1 tumor status had a greater HR for 2-year EFS (HR, 0.75; 95% CI, 0.62-0.91) compared with those with low (HR, 0.61; 95% CI, 0.37-0.71) or high (HR, 0.40; 95% CI, 0.27-0.58) PD-L1 (P = .005 for test of group differences). Here, CD274 is linked to neoplasm.